Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
Published on August 3, 2022
The lack of diversity in clinical trials unfairly skews American medicine and costs billions of dollars a year in early deaths and poor health. Proven economic incentives to recruit more diverse participants can dramatically change the bigger picture.